Autophagy-associated immune dysregulation and hyperplasia in a patient with compound heterozygous mutations in ATG9A.
Autophagy
; 19(2): 678-691, 2023 02.
Article
en En
| MEDLINE
| ID: mdl-35838483
ABSTRACT
ABBREVIATIONS BCL2 BCL2 apoptosis regulator; BCL10 BCL10 immune signaling adaptor; CARD11 caspase recruitment domain family member 11; CBM CARD11-BCL10-MALT1; CR2 complement C3d receptor 2; EBNA Epstein Barr nuclear antigen; EBV Epstein-Barr virus; FCGR3A; Fc gamma receptor IIIa; GLILD granulomatous-lymphocytic interstitial lung disease; HV healthy volunteer; IKBKB/IKB kinase inhibitor of nuclear factor kappa B kinase subunit beta; IL2RA interleukin 2 receptor subunit alpha; MALT1 MALT1 paracaspase; MS4A1 membrane spanning 4-domain A1; MTOR mechanistic target of rapamycin kinase; MYC MYC proto-oncogene, bHLH transcription factor; NCAM1 neural cell adhesion molecule 1; NFKB nuclear factor kappa B; NIAID National Institute of Allergy and Infectious Diseases; NK natural killer; PTPRC protein tyrosine phosphatase receptor type C; SELL selectin L; PBMCs peripheral blood mononuclear cells; TR T cell receptor; Tregs regulatory T cells; WT wild-type.
Palabras clave
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Infecciones por Virus de Epstein-Barr
Tipo de estudio:
Risk_factors_studies
Límite:
Humans
Idioma:
En
Revista:
Autophagy
Año:
2023
Tipo del documento:
Article
País de afiliación:
Estados Unidos